Categories Earnings, Technology
SurveyMonkey’s (SVMK) bottom line and topline figures for Q4 2019 beat estimates
SurveyMonkey (NASDAQ: SVMK), a provider of survey software solutions, bettered bottom line and topline targets for Q4 2019. The company reported an adjusted loss of 2 cents per share on revenue of $84.3 million. Analysts had estimated the company to post a loss of 4 cents per share on revenue of $83.83 million. SVMK stock gained about 3% in the after-market hours.
GAAP net loss per share shrunk to $0.16 from a loss of $0.20 per share in the prior-year quarter. In Q4, enterprise sales revenue grew 145% year-over-year, to approximately 25% of total revenue, up from 13% last year.
The San Mateo, California-based firm ended the quarter with 6,578 enterprise sales customers, up 84% from Q4 2018. SurveyMonkey added 468 new enterprise sales customers during the quarter, and over 3,000 during the year, Paying users increased 11% annually to 720,921 at the end of Q4 2019. Average revenue per user rose 10% to $467.
For fiscal 2020, SurveyMonkey targets revenue to be between $375 million and $381 million, representing a growth of 22-24%. For the first quarter of fiscal 2020, the company estimates revenue to be between $85 million and $86 million, representing a growth of 25%.
Shares of SurveyMonkey had gained 11% in the past three months and 31% from this time last year.
Most Popular
Microsoft (MSFT) reports higher revenue and profit for Q3 2024
Microsoft Corp. (NASDAQ: MSFT) on Thursday said its third-quarter 2024 earnings increased year-over-year, reflecting strong performance by the tech giant’s main operating segments. Third-quarter revenues came in at $61.86 billion,
GOOG, GOOGL Earnings: All you need to know about Alphabet’s Q1 2024 earnings results
Alphabet Inc. (NASDAQ: GOOG, GOOGL) reported its first quarter 2024 earnings results today. Revenues increased 15% year-over-year to $80.5 billion. Revenue growth was 16% in constant currency. Net income was
MRK Earnings: Merck Q1 2024 profit jumps on 9% revenue growth
Pharmaceutical company Merck & Co. Inc. (NYSE: MRK) reported a sharp increase in adjusted earnings for the first quarter of 2024, aided by an increase in revenues. First-quarter worldwide sales